IMPROVING ORGANIZATIONS BY REPLACING THE "MECHANICAL" MODEL WITH THE "ORGANIC" ONE



Potent anti-tumor effect generated by a novel human papillomavirus (HPV) antagonist peptide reactivating the pRb/E2F pathway.

Human papillomavirus type 16 (HPV16) E7 is a viral oncoprotein believed to play a major role in cervical cancer.In this study, an antagonist peptide against HPV16E7 protein was first identified from screening the c7c phage display peptide library.The binding specificity and affinity of the selected peptide to HPV16E7 were tested by competitive enzy

read more